In: PATENT NEWS
Although few people would contest China’s right to determine its own technological standards, exporting those standards is another matter altogether. Billions of dollars in equipment sales and patent royalties are up for grabs in this competition. To the extent that China’s standards supplant Western ones …
In: PATENT NEWS
However, this change could present new challenges for IP experts. For example, if a software project is backed by IP law and not open source, then how much of the code can be re-used in similar projects? Also, current patent laws don’t require filers to submit a single line of... Continue reading
In: PATENT NEWS
For example, at least one UK IP law firm has opted not to open a new office in London due to the associated uncertainty. Of course, this impact has …
In: PATENT NEWS
Drug companies say their lobbying reflects the fact that they are concerned about myriad issues, including Medicare and Medicaid, trade and taxes, patent rights, drug regulation, opioids and the budget for biomedical research. They have prepared an elaborate response to criticism of their pricing …
In: PATENT NEWS
the law of patents and registration of invention and design in manufacture with statutes forms and rules thomas turner on amazoncom free shipping on …
In: PATENT NEWS
Patent and trademark officials say cash incentives could be a factor. … expert at Berkeley Law School and former senior counsel at the patent office.
In: PATENT NEWS
I have an engineering undergrad and am interested in patent law. I’ve heard certain patent law jobs can start at $160K or so with decent hours,…
In: PATENT NEWS
Practising Law Institute (PLI) will be holding a program entitled “USPTO Post-Grant Patent Trials 2018: Change & Recalibration” in San Francisco …
In: PATENT NEWS
The Intellectual Property (IP) Law forum is for Australian legal topics related to copyright law, trade mark law, domain name law and cybersquatting …
In: PATENT NEWS
… myriad issues, including Medicare and Medicaid, trade and taxes, patent rights, drug regulation, opioids and the budget for biomedical research.
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION